AMOR RAPARLA: Open Payments
NPI 1275064370 · SUWANEE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,084 in 23 payments from 11 companies in 2025. Trend: 2023 $54 · 2024 $748 · 2025 $1,084
Food & beverage: $1,084
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $243 |
| Kowa Pharmaceuticals America, Inc. | 9 | $211 |
| Neurocrine BioSciences, Inc. | 2 | $153 |
| Astellas Pharma US Inc | 1 | $129 |
| Gilead Sciences, Inc. | 1 | $122 |
| AstraZeneca Pharmaceuticals LP | 1 | $116 |
| Merck Sharp & Dohme LLC | 2 | $31 |
| PFIZER INC. | 1 | $23 |
| bioMerieux Inc | 1 | $20 |
| SANOFI PASTEUR INC. | 1 | $20 |
Products named: ZORYVE, Veozah, Descovy, Wegovy, AIRSUPRA, PREVNAR 20, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, Doc Band.
Industry payments across GA — which companies pay providers there.
